An enzyme-linked immunosorbent assay (EIA) (MikroTrak; Syva) was compared with PCR (Amplicor; Roche) for detection of Chlamydia trachomatis in first-void urine (FVU) from 184 men attending a skin and venereal disease clinic. The prevalence of C. trachomatis in the population studied was 18.5%. Discrepant results between Syva EIA and Roche PCR were retested by using major outer membrane protein primer-based PCR. After retesting, the sensitivity, the specificity, and the positive and negative predictive values for the Syva EIA were 85.3, 100, 100, and 77.5%, respectively, and those for the Roche PCR 100, 100, 100, and 100%, respectively. It was concluded that PCR provides a highly sensitive and specific noninvasive screening method for genital chlamydial infection in asymptomatic men.
Detection of chlamydial antigen in sediments of first-void urine (FVU) from men is a feasible and accurate test for chlamydial urethritis (5, 13, 20) . The use of FVU, especially for asymptomatic carriers, is more acceptable to males than urethral swabbing (4) . The clinical and epidemiological implications associated with undetected genital chlamydial infections demand a rapid and accurate laboratory screening test (12, 21, 23) .
Asymptomatic male carriers of Chlamydia trachomatis are of particular concern because the infection may be passed to female partners, resulting in pelvic inflammatory disease and its sequelae, i.e., ectopic pregnancy and infertility.
Our study was aimed at evaluating a PCR test for the detection of C. trachomatis in male FVU and comparing it with an enzyme immunoassay (EIA) test.
MATERIALS AND METHODS
Study population. FVU from asymptomatic males (n = 184) presenting at a skin and venereal disease clinic, for reasons other than venereal disease, was collected. Patients were supplied with 20-ml urine tubes and were asked to return after having collected their early-morning urine. The median age of the patients was 32 years.
Specimen collection and preparation. Fresh urine was divided into two aliquots of 10 ml each. One aliquot of urine was immediately centrifuged at 1,500 x g for 15 min, and the pellet was resuspended in 1 ml of Syva MicroTrak specimen treatment solution. The samples were kept at 4°C for .2 weeks before being investigated.
The other aliquot of urine was frozen at -20°C and kept for about 2 weeks until the PCR was done. Before the investigation, urine was thawed at room temperature and then heated for 30 min at 37°C to dissolve any precipitate. Then the specimens were vortexed (=1 min) and centrifuged at 1,500 x g for 10 min at room temperature. The supernatants were replaced with 2 ml of Roche Amplicor urine resuspension buffer and kept for 1 h at room temperature. After 2 ml of urine diluent had been added, the sample was left for 10 min at room temperature before amplification. Genital infections caused by C. trachomatis have traditionally been detected by cell culture, but for urine, culture is a highly insensitive method to detect a genital chlamydial infection (5).
For this reason, noninvasive antigen detection tests, such as DIF (11) and EIA (5, 9, 14) , have been proposed as alternative diagnostic means. Two DNA amplification techniques for the detection of urogenital infections due to C. trachomatis have been developed, i.e., PCR and ligase chain reaction (1, 6, 12, 24) .
In general, PCR has been shown to be highly sensitive for detection of C. trachomatis in clinical specimens. Several PCR-based assays that have used plasmid primers (12, 17, 19) , the MOMP gene (2, 3), or rRNA (8, 25) for detection of C. trachomatis infection have been described.
However, when dealing with PCR, a few possible difficulties need to be overcome.
One problem associated with PCR is sample contamination. Concerns about false positives due to amplimer contamination of specimens have urged poststerilization procedures for the improvement of specificity (7) .
Some samples, e.g., urine, may possess inhibitory substances interfering with PCR results. The major factor affecting the sensitivity of this assay seems to be the activity of Taq polymerase, which can be blocked by the presence of Taq polymerase inhibitors (18) .
The evaluation of the results of nucleic acid detection and amplification techniques, such as PCR and ligase chain reaction, which in most cases are more sensitive than other methods used for the diagnosis of genital chlamydial infections, e.g., cell culture and EIA, has often met with difficulties. Therefore, a general strategy to use at least two other independent test systems when evaluating new tests has been proposed (22) . One of those systems in the case of PCR is the use of different sets of primers which are equally sensitive and able to confirm positive findings (15, 16 (1, 12) .
PCR has been shown to be cost-effective for screening of adolescent males for C. trachomatis (10) . Our study indicates that PCR is a suitable method for the detection of genital chlamydial infections in FVU samples from asymptomatic males.
